The expanding role of Real-world Evidence in early clinical development
Why collecting Real World Data is important to optimize clinical trials and get new medical product approved? In clinical development, the traditional approach to demonstrate
EDC
One size does not fit all
Safety Notification
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections
eTMF
Essential document collection
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Managed Service Model for MDR
Migration, Consulting and Customization for your MDR
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
Why collecting Real World Data is important to optimize clinical trials and get new medical product approved? In clinical development, the traditional approach to demonstrate
I’m Thierry Hillewaere, global product marketing lead at EvidentIQ and I recently met with Manuel Neukum, Chief Operating Officer at EvidentIQ. Over the past years eConsent software, which helps
I’m Gilda Teissier, Marketing Director at EvidentIQ and I recently met with Emilie Pain, Data Scientist at Carenity, part of the EvidentIQ Group. Whether to develop new products, services,
I’m Gilda Teissier, Marketing Director at EvidentIQ and I recently met with Simon Taylor, Director of Solution Consulting at EvidentIQ Modern Clinical trials have undergone a huge shift in the
Are you interested in Virtual Trials? You have heard about it, but not sure whether this approach is the most appropriate for you? You want
Are you interested in Preference studies? You have heard about DCE, but not sure whether this approach is the most appropriate for you? You want
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2024 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us: